Updated recommendations on the use of herpes zoster vaccines . : HP40-212/2018E-PDF
"The need for this updated National Advisory Committee on Immunization (NACI) Advisory Committee Statement on the Use of Herpes Zoster (HZ) Vaccines was triggered by evidence on a newly authorized Recombinant subunit Zoster Vaccine (RZV) vaccine, Shingrix®, indicated for the prevention of HZ in individuals 50 years of age and older. The primary objective of this statement is to review current evidence and develop guidance on the use of Shingrix®, as well as to provide guidance on whether the previously authorized Live Zoster Vaccine (LZV), Zostavax®II, and/or the recently authorized RZV should be offered to Canadians ≥50 years of age and older"--Introd., p. 6.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.853982&sl=1
| Ministère/Organisme | Public Health Agency of Canada. Infectious Disease Prevention and Control Branch. |
|---|---|
| Titre | Updated recommendations on the use of herpes zoster vaccines . |
| Variante du titre | At head of title: Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI) |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique | |
| Note(s) | Issued also in French under title: Recommandations à jour sur l’utilisation des vaccins contre le zona. Includes bibliographic references: p. 63-72. |
| Information sur la publication | Ottawa : Public Health Agency of Canada,2018. |
| Description | 177 p. : col. charts. |
| ISBN | 9780660258522 |
| Numéro de catalogue |
|
| Numéro de catalogue du ministère | Pub.: 170531 |
| Descripteurs | Immunization Infectious diseases |
Demander des formats alternatifs
Pour demander une publication dans un format alternatif, remplissez le formulaire électronique des publications du gouvernement du Canada. Utilisez le champ du formulaire «question ou commentaire» pour spécifier la publication demandée.- Date de modification :